by PRI | Jun 21, 2022 | Non classé
Ana Montalban-Arques CEO Recolony Recolony focuses on the development of a live biotherapeutic product for the treatment or prevention of colorectal cancer....
by PRI | Jun 20, 2022 | Microbiome Product Developer
Tomas de Wouters Co-Founder & CEO Pioneering the development of microbiome-based therapies using proprietary tools for their design and production....
by PRI | Jun 20, 2022 | Pharma (Human)
Laurent Ameye Global Regulatory Compliance Manager Our expertise areas includes food supplements, medical nutrition, and pharmaceutical solutions on areas including food allergies, metabolic/gastrointestinal health, healthy aging and adult acute care....
by PRI | Jun 17, 2022 | Pharma (Human)
Adam Jarlfors Global Regulatory Lead Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives....
by PRI | Jun 17, 2022 | Microbiome Research & Technology (public)
Christophe Lacroix Professor Public university...
